{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:51:50Z","timestamp":1788292310478,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["2017R1A2B4005052"],"award-info":[{"award-number":["2017R1A2B4005052"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0224247","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T18:11:28Z","timestamp":1571854288000},"page":"e0224247","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2464-0665","authenticated-orcid":true,"given":"Hee Young","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Young","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ah","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3010-448X","authenticated-orcid":true,"given":"So Hee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"issue":"3","key":"pone.0224247.ref001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V99.3.815","article-title":"De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients","volume":"99","author":"M Yamaguchi","year":"2002","journal-title":"Blood"},{"issue":"1","key":"pone.0224247.ref002","first-page":"207","article-title":"De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct","volume":"147","author":"A Matolcsy","year":"1995","journal-title":"Am J Pathol"},{"issue":"3","key":"pone.0224247.ref003","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1309\/AJCP58FETFGLCKKW","article-title":"Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma (Richter syndrome)","volume":"131","author":"AM Maeshima","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"pone.0224247.ref004","author":"SH Swerdlow","year":"2017"},{"issue":"9","key":"pone.0224247.ref005","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ajh.23467","article-title":"Recent advances in de novo CD5+ diffuse large B cell lymphoma","volume":"88","author":"P Jain","year":"2013","journal-title":"Am J Hematol"},{"key":"pone.0224247.ref006","author":"SH Swerdlow","year":"2008"},{"issue":"1","key":"pone.0224247.ref007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hon.896","article-title":"The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma","volume":"28","author":"R Hyo","year":"2010","journal-title":"Hematol Oncol"},{"issue":"4","key":"pone.0224247.ref008","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-2141.1999.01513.x","article-title":"De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome","volume":"105","author":"M Yamaguchi","year":"1999","journal-title":"Br J Haematol"},{"issue":"16","key":"pone.0224247.ref009","first-page":"14720","article-title":"Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries (vol 8, pg 5615, 2015)","volume":"6","author":"ZY Xu-Monette","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"pone.0224247.ref010","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/annonc\/mdq627","article-title":"CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab","volume":"22","author":"K Miyazaki","year":"2011","journal-title":"Annals of Oncology"},{"issue":"4","key":"pone.0224247.ref011","first-page":"523","article-title":"De Novo CD5+diffuse large B-Cell lymphomas\u2014A heterogeneous group containing an unusual form of splenic lymphoma","volume":"114","author":"SH Kroft","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"pone.0224247.ref012","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ajh.24299","article-title":"De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort","volume":"91","author":"L Alinari","year":"2016","journal-title":"Am J Hematol"},{"issue":"8","key":"pone.0224247.ref013","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3324\/haematol.12810","article-title":"De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients","volume":"93","author":"M Yamaguchi","year":"2008","journal-title":"Haematologica"},{"issue":"1","key":"pone.0224247.ref014","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/10428190903324244","article-title":"De novo CD5+ diffuse large B-cell lymphoma: a distinct subset with adverse features, poor failure-free survival and outcome with conventional therapy","volume":"51","author":"J Westin","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"pone.0224247.ref015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/ejh.12847","article-title":"Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH","volume":"98","author":"B Thakral","year":"2017","journal-title":"Eur J Haematol"},{"issue":"1","key":"pone.0224247.ref016","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"CP Hans","year":"2004","journal-title":"Blood"},{"issue":"28","key":"pone.0224247.ref017","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"NA Johnson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"pone.0224247.ref018","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/modpathol.2017.93","article-title":"Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma","volume":"30","author":"AE Quesada","year":"2017","journal-title":"Mod Pathol"},{"key":"pone.0224247.ref019","article-title":"Classification of malignant lymphoma subtypes in Korean patients: a report of the 4th nationwide study","author":"H-R Jung","year":"2019","journal-title":"Journal of Hematopathology"},{"issue":"5","key":"pone.0224247.ref020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00428-015-1845-1","article-title":"CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma","volume":"467","author":"WY Chuang","year":"2015","journal-title":"Virchows Arch"},{"issue":"11","key":"pone.0224247.ref021","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/annonc\/mdn392","article-title":"CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy","volume":"19","author":"D Ennishi","year":"2008","journal-title":"Ann Oncol"},{"key":"pone.0224247.ref022","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-015-0168-7","article-title":"Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38\/07 study","volume":"8","author":"A Tzankov","year":"2015","journal-title":"J Hematol Oncol"},{"issue":"1","key":"pone.0224247.ref023","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/16078454.2019.1614289","article-title":"Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma","volume":"24","author":"H Tang","year":"2019","journal-title":"Hematology"},{"issue":"2","key":"pone.0224247.ref024","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2016.09.004","article-title":"High grade B-cell lymphoma with rearrangements of MYC and BCL2 and\/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma","volume":"31","author":"A Rosenthal","year":"2017","journal-title":"Blood Rev"},{"issue":"4","key":"pone.0224247.ref025","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3324\/haematol.2015.134213","article-title":"Impact of post-brentuximab vedotin consolidation on relapsed\/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program","volume":"101","author":"A Perrot","year":"2016","journal-title":"Haematologica"},{"issue":"15","key":"pone.0224247.ref026","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1016\/S1470-2045(15)00005-4","article-title":"Double-hit and double-protein-expression lymphomas: aggressive and refractory lymphomas","volume":"16","author":"C Sarkozy","year":"2015","journal-title":"Lancet Oncol"},{"issue":"3","key":"pone.0224247.ref027","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18632\/oncotarget.6262","article-title":"Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma","volume":"7","author":"Q Ye","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0224247.ref028","doi-asserted-by":"crossref","first-page":"14814","DOI":"10.1038\/s41598-018-33230-3","article-title":"Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP.","volume":"8","author":"P Peroja","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"pone.0224247.ref029","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1158\/1535-7163.MCT-17-0089","article-title":"Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas","volume":"16","author":"S Islam","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"pone.0224247.ref030","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"S Hu","year":"2013","journal-title":"Blood"},{"issue":"2","key":"pone.0224247.ref031","doi-asserted-by":"crossref","first-page":"e0172364","DOI":"10.1371\/journal.pone.0172364","article-title":"Diffuse large B-cell lymphoma with concurrent high MYC and BCL2 expression shows evidence of active B-cell receptor signaling by quantitative immunofluorescence","volume":"12","author":"AM Bogusz","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"pone.0224247.ref032","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-08-0325","article-title":"Epigenetic silencing of microRNA-34b\/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer","volume":"68","author":"M Toyota","year":"2008","journal-title":"Cancer Res"},{"issue":"2","key":"pone.0224247.ref033","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gene.2011.12.027","article-title":"Regulation of gene transcription by the oncoprotein MYC","volume":"494","author":"B Luscher","year":"2012","journal-title":"Gene"},{"issue":"11","key":"pone.0224247.ref034","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/modpathol.2016.128","article-title":"PELI1 expression is correlated with MYC and BCL6 expression and associated with poor prognosis in diffuse large B-cell lymphoma","volume":"29","author":"JY Choe","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"pone.0224247.ref035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/his.12760","article-title":"MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma","volume":"68","author":"JY Choe","year":"2016","journal-title":"Histopathology"},{"issue":"1","key":"pone.0224247.ref036","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2007.11.013","article-title":"Transitional B cells in humans: Characterization and insight from B lymphocyte reconstitution after hematopoietic stem cells transplantation","volume":"127","author":"A Marie-Cardine","year":"2008","journal-title":"Clin Immunol"},{"key":"pone.0224247.ref037","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0065-2776(08)60663-X","article-title":"The CD5 B cell","volume":"47","author":"TJ Kipps","year":"1989","journal-title":"Adv Immunol"},{"issue":"2","key":"pone.0224247.ref038","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.136.2.505","article-title":"Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies","volume":"136","author":"JH Antin","year":"1986","journal-title":"J Immunol"},{"issue":"6","key":"pone.0224247.ref039","first-page":"954","article-title":"Follicular origin of a subset of CD5(+) diffuse large B-cell lymphomas","volume":"125","author":"MA Catherwood","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"pone.0224247.ref040","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/cncr.30404","article-title":"MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma","volume":"123","author":"T Takeuchi","year":"2017","journal-title":"Cancer"},{"issue":"13","key":"pone.0224247.ref041","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1182\/blood-2002-05-1525","article-title":"Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production","volume":"100","author":"H Gary-Gouy","year":"2002","journal-title":"Blood"},{"issue":"6282","key":"pone.0224247.ref042","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"SC Casey","year":"2016","journal-title":"Science"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0224247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T14:54:07Z","timestamp":1721919247000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224247"}},"subtitle":[],"editor":[{"given":"Joseph S.","family":"Pagano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0224247","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,23]]}}}